Clinical Data

eyeball eye disease eyelash eyes
Biotech

Ollin eyes phase 3 after topping Vabysmo in early-stage trial

Given the findings, the Texas-based biotech is now planning to launch global phase 3 studies this year.
Gabrielle Masson Jan 8, 2026 3:20pm
Racecar speeding down a track

Immuneering touts 64% survival, fueling race with Revolution

Jan 8, 2026 5:17am
Curtains closing on an empty stage

Pulmocide pulls ph. 3 antifungal trial over mortality rate

Jan 7, 2026 10:57am
GSK ESMO

GSK's 'functional cure' for hep B proves worth in ph. 3 trials

Jan 7, 2026 6:15am
An arrow incrementally going up stairs before pointing straight up Blue background

Hutchmed heats up autoimmune race with phase 3 win

Jan 7, 2026 4:39am
Lightbulb with an image of a brain inside

Bright Minds anti-seizure candidate shines in phase 2 win

Jan 6, 2026 10:38am